These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10415147

  • 1. Nicotine alone and in combination with L-DOPA methyl ester or the D(2) agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H.
    Exp Neurol; 1999 Aug; 158(2):414-21. PubMed ID: 10415147
    [Abstract] [Full Text] [Related]

  • 2. Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
    Domino EF, Ni L.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):81-5. PubMed ID: 18851961
    [Abstract] [Full Text] [Related]

  • 3. Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism.
    Domino EF.
    Brain Res Bull; 1997 Dec 03; 43(1):93-5. PubMed ID: 9205801
    [Abstract] [Full Text] [Related]

  • 4. Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Ni L.
    J Pharmacol Exp Ther; 1998 Jan 03; 284(1):307-11. PubMed ID: 9435192
    [Abstract] [Full Text] [Related]

  • 5. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jan 03; 264(1):221-5. PubMed ID: 8093726
    [Abstract] [Full Text] [Related]

  • 6. Effects of (+/-)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Ni L, Colpaert F, Marien M.
    Recept Channels; 2003 Jan 03; 9(5):335-8. PubMed ID: 14527878
    [Abstract] [Full Text] [Related]

  • 7. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK, Banerji T, Jenner P, Marsden CD.
    Mov Disord; 1998 Mar 03; 13(2):234-41. PubMed ID: 9539335
    [Abstract] [Full Text] [Related]

  • 8. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jun 03; 265(3):1387-91. PubMed ID: 8099621
    [Abstract] [Full Text] [Related]

  • 9. Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
    Irifune M, Nomoto M, Fukuda T.
    Eur J Pharmacol; 1994 Oct 24; 264(2):117-23. PubMed ID: 7851473
    [Abstract] [Full Text] [Related]

  • 10. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 24; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 11. The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates.
    Zubair M, Jackson MJ, Tayarani-Binazir K, Stockwell KA, Smith LA, Rose S, Olanow W, Jenner P.
    Exp Neurol; 2007 Dec 24; 208(2):177-84. PubMed ID: 17935716
    [Abstract] [Full Text] [Related]

  • 12. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
    Kanda T, Jackson MJ, Smith LA, Pearce RK, Nakamura J, Kase H, Kuwana Y, Jenner P.
    Exp Neurol; 2000 Apr 24; 162(2):321-7. PubMed ID: 10739638
    [Abstract] [Full Text] [Related]

  • 13. MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.
    Emborg-Knott ME, Domino EF.
    Exp Neurol; 1998 Aug 24; 152(2):214-20. PubMed ID: 9710520
    [Abstract] [Full Text] [Related]

  • 14. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    J Pharmacol Exp Ther; 1998 Dec 24; 287(3):983-7. PubMed ID: 9864283
    [Abstract] [Full Text] [Related]

  • 15. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 24; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 16. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L.
    Exp Neurol; 1998 Aug 24; 152(2):238-42. PubMed ID: 9710523
    [Abstract] [Full Text] [Related]

  • 17. N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.
    Belluzzi JD, Domino EF, May JM, Bankiewicz KS, McAfee DA.
    Mov Disord; 1994 Mar 24; 9(2):147-54. PubMed ID: 7910948
    [Abstract] [Full Text] [Related]

  • 18. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Synapse; 2006 Sep 01; 60(3):239-50. PubMed ID: 16739115
    [Abstract] [Full Text] [Related]

  • 19. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ, Konitsiotis S, Chase TN.
    J Pharmacol Exp Ther; 1997 Nov 01; 283(2):794-9. PubMed ID: 9353400
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys.
    Arai N, Isaji M, Kojima M, Mizuta E, Kuno S.
    J Neural Transm (Vienna); 1996 Nov 01; 103(11):1307-16. PubMed ID: 9013417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.